Citation Impact
Citing Papers
Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy
2001 StandoutScience
Protein characterization of Saccharomyces cerevisiae RNA polymerase II after in vivo cross-linking
2007 StandoutNobel
Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O 2 -Regulated Prolyl Hydroxylation
2001 StandoutScienceNobel
Structural Basis of Transcription: Backtracked RNA Polymerase II at 3.4 Angstrom Resolution
2009 StandoutScienceNobel
RNA polymerase II trigger loop residues stabilize and position the incoming nucleotide triphosphate in transcription
2010 StandoutNobel
Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein
2000 StandoutNobel
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
Analysis of the genome sequence of the flowering plant Arabidopsis thaliana
2000 StandoutNature
Cdc53 is a scaffold protein for multiple Cdc34/Skp1/F-box protein complexes that regulate cell division and methionine biosynthesis in yeast
1998
The NEDD8 Pathway Is Essential for SCFβ-TrCP-mediated Ubiquitination and Processing of the NF-κB Precursor p105
2002 StandoutNobel
Structural Basis of Transcription: Role of the Trigger Loop in Substrate Specificity and Catalysis
2006 StandoutNobel
MUF1, A Novel Elongin BC-interacting Leucine-rich Repeat Protein That Can Assemble with Cul5 and Rbx1 to Reconstitute a Ubiquitin Ligase
2001
The F-box protein family.
2000
A Complex of the Srb8, -9, -10, and -11 Transcriptional Regulatory Proteins from Yeast
2002 StandoutNobel
Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex
2001 StandoutNobel
The von Hippel-Lindau tumor suppressor protein is a component of an E3 ubiquitin-protein ligase activity
1999
Ubiquitin-Proteasome-mediated Degradation of Id1 Is Modulated by MyoD
2004 StandoutNobel
Fundamental Cellular Processes Do Not Require Vertebrate-specific Sequences within the TATA-binding Protein
2003 StandoutNobel
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
1999 StandoutNatureNobel
Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage
2003 StandoutNatureNobel
Combinatorial control in ubiquitin-dependent proteolysis: don't Skp the F-box hypothesis
1998
von Hippel-Lindau Disease
1997 StandoutNobel
F-Box Proteins Are Receptors that Recruit Phosphorylated Substrates to the SCF Ubiquitin-Ligase Complex
1997
The Nuclear Ubiquitin-Proteasome System Degrades MyoD
2001 StandoutNobel
Quantitation of the RNA Polymerase II Transcription Machinery in Yeast
2001 StandoutNobel
Identification of the Ubiquitin Carrier Proteins, E2s, Involved in Signal-induced Conjugation and Subsequent Degradation of IκBα
1999 StandoutNobel
The Histone Chaperone Spt6 Is Required for Activation-induced Cytidine Deaminase Target Determination through H3K4me3 Regulation
2012 StandoutNobel
Interaction of Steroid Hormone Receptors with the Transcription Initiation Complex
1996
The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families
1998 StandoutNobel
HIF hydroxylation and the mammalian oxygen-sensing pathway
2003 StandoutNobel
Suppression of inflammation by a synthetic histone mimic
2010 StandoutNatureNobel
Identification of a mouse TBP-like protein (TLP) distantly related to the Drosophila TBP-related factor
1999
Molecular basis of agonism and antagonism in the oestrogen receptor
1997 StandoutNature
The general transcription factors of RNA polymerase II.
1996
Selection of Mutant CHO Cells with Constitutive Activation of the HIF System and Inactivation of the von Hippel-Lindau Tumor Suppressor
2001 StandoutNobel
Elongation by RNA polymerase II: the short and long of it
2004
Two-Dimensional Crystallography of TFIIB– and IIE–RNA Polymerase II Complexes: Implications for Start Site Selection and Initiation Complex Formation
1996 StandoutNobel
Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway
2008 StandoutNobel
Identification of Elongin C Sequences Required for Interaction with the von Hippel-Lindau Tumor Suppressor Protein
1997
Proteolysis and the G1-S transition: the SCF connection
1998
Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb
1998 StandoutNature
Electron Crystal Structure of an RNA Polymerase II Transcription Elongation Complex
1999 StandoutNobel
The VHL tumour-suppressor gene paradigm
1998 StandoutNobel
A Minimal Set of RNA Polymerase II Transcription Protein Interactions
1996 StandoutNobel
Accumulation of the FACT complex, as well as histone H3.3, serves as a target marker for somatic hypermutation
2013 StandoutNobel
Diffusion of nucleoside triphosphates and role of the entry site to the RNA polymerase II active center
2004 StandoutNobel
Transcription Elongation and Human Disease
1999
Protective Function of von Hippel-Lindau Protein against Impaired Protein Processing in Renal Carcinoma Cells
1999
Hypoxia-inducible factor 1α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations
2000 StandoutNobel
Rbx1, a Component of the VHL Tumor Suppressor Complex and SCF Ubiquitin Ligase
1999 StandoutScienceNobel
The yeast GAL11 protein binds to the transcription factor IIE through GAL11 regions essential for its in vivo function.
1996 StandoutNobel
von Hippel-Lindau Disease
2006 StandoutNobel
COI1 : An Arabidopsis Gene Required for Jasmonate-Regulated Defense and Fertility
1998 StandoutScience
HIF hydroxylation and the mammalian oxygen-sensing pathway
2003 StandoutNobel
The role of general initiation factors in transcription by RNA polymerase II
1996
Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor
2002 StandoutNobel
BASIC MECHANISMS OF TRANSCRIPT ELONGATION AND ITS REGULATION
1997
Kinase requirements in human cells: III. Altered kinase requirements inVHL−/− cancer cells detected in a pilot synthetic lethal screen
2008 StandoutNobel
pVHL 19 is a biologically active product of the von Hippel–Lindau gene arising from internal translation initiation
1998 StandoutNobel
The RNA Polymerase II Elongation Complex
2003
pVHL suppresses kinase activity of Akt in a proline-hydroxylation–dependent manner
2016 StandoutScienceNobel
Structure of the VHL-ElonginC-ElonginB Complex: Implications for VHL Tumor Suppressor Function
1999 StandoutScienceNobel
Roles for both the RAP30 and RAP74 subunits of transcription factor IIF in transcription initiation and elongation by RNA polymerase II.
1994
Structure of an HIF-1α-pVHL Complex: Hydroxyproline Recognition in Signaling
2002 StandoutScienceNobel
The requirement for the basal transcription factor IIE is determined by the helical stability of promoter DNA.
1995
TRANSCRIPTION OF EUKARYOTIC PROTEIN-CODING GENES
2000
Architecture of RNA Polymerase II and Implications for the Transcription Mechanism
2000 StandoutScienceNobel
Emerging Roles of Ubiquitin in Transcription Regulation
2002 Science
Regulation of Hypoxia-Inducible mRNAs by the von Hippel-Lindau Tumor Suppressor Protein Requires Binding to Complexes Containing Elongins B/C and Cul2
1998 StandoutNobel
The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction
2002 StandoutNobel
Structural Basis of Transcription: RNA Polymerase II at 2.8 Ångstrom Resolution
2001 StandoutScienceNobel
Association of the Mediator complex with enhancers of active genes
2003 StandoutNobel
Works of Teppei Aso being referenced
Role of core promoter structure in assembly of the RNA polymerase II preinitiation complex. A common pathway for formation of preinitiation intermediates at many TATA and TATA-less promoters
1994
The inducible elongin A elongation activation domain: structure, function and interaction with the elongin BC complex.
1996
A TATA sequence-dependent transcriptional repressor activity associated with mammalian transcription factor IIA.
1994